Basic aspects of Catechol-O-methyltransferase and the clinical applications of its inhibitors

Edited by

  • Erkki Nissinen, Orion Corporation, Espoo, Finland

Volume 95 of International Review of Neurobiology focuses on Catechol-O-methyltransferase inhibition, and its clinical application in relation to Parkinson√ʬĬôs disease. Chapters cover COMT gene and proteins, L-dopa treatment in Parkinson√ʬĬôs disease, the latest research on COMT inhibitors and their clinical applications, as well as future prospects for their use.
View full description

Audience

Neuroscientists, neurologists, psychologists, gerontologists

 

Book information

  • Published: December 2010
  • Imprint: ACADEMIC PRESS
  • ISBN: 978-0-12-381326-8


Table of Contents

  1. Introductory remarks: Catechol-O-methyltransferase inhibition: an innovative approach to enhance L-dopa therapy in Parkinson√ʬĬôs disease with dual enzyme inhibition
  2. Erkki Nissinen

  3. The catechol-O-methyltransferase gene, its regulation and polymorphisms
  4. Elizabeth M. Tunbridge

  5. Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture?
  6. Timo T. Myöhänen & Pekka T. Männistö

  7. Catechol-O-methyltransferase enzyme: Cofactor S-adenosyl-L-methionine and related mechanisms
  8. Thomas M√ɬľller

  9. Biochemistry and pharmacology of catechol-O-methyltrasferase inhibitors
  10. Erkki Nissinen and Pekka T. Männistö

  11. The Chemistry of Catechol-O-methyltransferase Inhibitors
  12. David A. Learmonth, László E. Kiss and Patrício Soares-da-Silva

  13. Toxicology and safety of COMT inhibitors
  14. Kristiina Haasio

  15. Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of the L-dopa treatment
  16. Concepció Marin, J.A. Obeso

  17. Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson√ʬĬôs disease
  18. Seppo Kaakkola

  19. Catechol-O-methyltransferase and pain

Oleg Kambur & Pekka T. Männistö